tirzepatide long term safety Dos and Don'ts: Essential Guidelines Long-Term Safety of Tirzepatide: What

Diabetes Care 44, 14621471

For both drugs, starting low and going slow can help your body acclimate to the medicine and reduce the risk of side effects

A Claims-Based Study of 30,458 Patients A retrospective cohort study using insurance claims and electronic health records compared 14,101 bariatric surgery patients (mean follow-up 34 months) against 16,357 GLP-1 patients (mean follow-up 32 months), all with class II or III obesity

Prediabetics who participated in the study showed improvement in blood sugar levels and had healthier microbiomes

Frequently asked questions What is a lyophilised peptide

Previous studies in mice have reported that matched, unbiased agonists are less effective at controlling glucose and body weight than GLP-1RAs with bias similar to that of tirzepatide [35, 36]